(R)-5-hydroxy-3',4',5',7-tetramethoxy-2'H-spiro[chroman-3,1'-cyclobutabenzen]-4-one

ID: ALA4515638

PubChem CID: 155539744

Max Phase: Preclinical

Molecular Formula: C20H20O7

Molecular Weight: 372.37

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc(O)c2c(c1)OC[C@]1(Cc3c1cc(OC)c(OC)c3OC)C2=O

Standard InChI:  InChI=1S/C20H20O7/c1-23-10-5-13(21)16-14(6-10)27-9-20(19(16)22)8-11-12(20)7-15(24-2)18(26-4)17(11)25-3/h5-7,21H,8-9H2,1-4H3/t20-/m0/s1

Standard InChI Key:  RWSCIOKDSXDRFY-FQEVSTJZSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    5.7794   -4.3920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7752   -5.2170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6002   -5.2211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6044   -4.3961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9194   -3.5623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9182   -4.3897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6330   -4.8025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6312   -3.1496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3465   -3.5587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3453   -4.3872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0583   -4.8001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7782   -3.5607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0607   -3.1433    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0560   -5.6251    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3120   -5.6359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0285   -5.2226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0256   -4.3921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3102   -3.9829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7385   -3.9768    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.7436   -5.6339    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3103   -6.4609    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5950   -6.8719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7449   -6.4589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4546   -4.3867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2048   -3.1500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2046   -2.3251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6346   -5.6275    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  6
  2  3  1  0
  3  4  2  0
  4  1  1  0
  5  6  2  0
  6  7  1  0
  7 10  2  0
  9  8  2  0
  8  5  1  0
  9 10  1  0
  9 13  1  0
 10 11  1  0
 11  1  1  0
  1 12  1  0
 12 13  1  0
 11 14  2  0
  3 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18  4  1  0
 17 19  1  0
 16 20  1  0
 15 21  1  0
 21 22  1  0
 20 23  1  0
 19 24  1  0
  5 25  1  0
 25 26  1  0
  7 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4515638

    ---

Associated Targets(Human)

Y79 (258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 372.37Molecular Weight (Monoisotopic): 372.1209AlogP: 2.50#Rotatable Bonds: 4
Polar Surface Area: 83.45Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 8.66CX Basic pKa: CX LogP: 2.87CX LogD: 2.84
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.88Np Likeness Score: 1.41

References

1. Schwikkard S, Whitmore H, Sishtla K, Sulaiman RS, Shetty T, Basavarajappa HD, Waller C, Alqahtani A, Frankemoelle L, Chapman A, Crouch N, Wetschnig W, Knirsch W, Andriantiana J, Mas-Claret E, Langat MK, Mulholland D, Corson TW..  (2019)  The Antiangiogenic Activity of Naturally Occurring and Synthetic Homoisoflavonoids from the Hyacinthaceae ( sensu APGII).,  82  (5): [PMID:30951308] [10.1021/acs.jnatprod.8b00989]

Source